Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

US Patent 11135220 · Granted Oct 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rotomeric isomers of 4-alkyl-5-heteroaryl-3H-1,2-dithiole-3-thiones2025
Antigen-binding fusion proteins with modified HSP70 domains2023
Purification of sulfentrazone herbicide using selective pH adjusted extractions2023
CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated disease2023
HSP fusion protein with anti-chemorepellant agent for treatment of infectious di2022
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods 2022
Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment 2022
HSP fusion protein with anti-chemorepellant agent for treatment of cancer2022
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modifi2021
Antimicrobial photodynamic inactivation procedure and system2021
Single step regioselective cyclization and chlorination of hydroxyamino-N-(2-met2021
Methods for preparing oltipraz2021